Who owns Clearside Biomedical?
- Ticker: CLSD
- CUSIP Number: 185063104
Tip: Access positions for across all investors
Analyze quarterly positions in Clearside Biomedical with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Clearside Biomedical stock
Who bought or sold Clearside Biomedical this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Armistice Capital | 4.0M | $6.1M | 100% | Mar 2024 |
|
Rosalind Advisors | 2.6M | $4.0M | 100% | Mar 2024 |
|
Vanguard Group | 2.5M | $3.8M | 14% | Mar 2024 |
|
Carmignac Gestion | 2.1M | $3.3M | 0% | Mar 2024 |
|
BlackRock | 758k | $1.2M | -1% | Mar 2024 |
|
Geode Capital Management | 642k | $983k | 31% | Mar 2024 |
|
Millennium Management | 207k | $317k | 515% | Mar 2024 |
|
Jane Street | 177k | $270k | 100% | Mar 2024 |
|
First Manhattan | 175k | $268k | 0% | Mar 2024 |
|
Johnson & Johnson | 170k | $260k | 0% | Mar 2024 |
|
Castleview Partners | 162k | $248k | 100% | Mar 2024 |
|
Morgan Stanley | 153k | $234k | -9% | Mar 2024 |
|
Northern Trust | 134k | $204k | 41% | Mar 2024 |
|
Bridgeway Capital Management | 130k | $199k | -26% | Mar 2024 |
|
Brown Wealth Management | 110k | $168k | 0% | Mar 2024 |
|
Northeast Financial Consultants | 93k | $142k | 0% | Mar 2024 |
|
Citadel Advisors | 79k | $121k | 23% | Mar 2024 |
|
Marshall Wace | 69k | $105k | 100% | Mar 2024 |
|
Captrust Financial Advisors | 50k | $77k | 0% | Mar 2024 |
|
Banque Cantonale Vaudoise | 40k | $61k | 0% | Mar 2024 |
|
Stifel Financial | 39k | $60k | 15% | Mar 2024 |
|
International Assets Investment Management | 36k | $57k | 100% | Mar 2024 |
|
Y-Intercept | 34k | $52k | 100% | Mar 2024 |
|
SG Americas Securities | 32k | $49k | 100% | Mar 2024 |
|
Connor, Clark & Lunn Investment Management | 25k | $39k | 100% | Mar 2024 |
|
Credit Suisse | 25k | $38k | 100% | Mar 2024 |
|
Curi Wealth Management | 25k | $29k | 0% | Dec 2023 |
|
Cubist Systematic Strategies | 25k | $38k | 100% | Mar 2024 |
|
Two Sigma Securities | 22k | $34k | 100% | Mar 2024 |
|
Charles Schwab Investment Management | 20k | $31k | 0% | Mar 2024 |
|
XTX Topco | 20k | $31k | -28% | Mar 2024 |
|
Mariner Wealth Advisors | 19k | $29k | 0% | Mar 2024 |
|
Susquehanna International | 14k | $22k | -91% | Mar 2024 |
|
Stratos Wealth Advisors | 14k | $21k | 0% | Mar 2024 |
|
Cambridge Investment Research Advisors | 11k | $17k | 5% | Mar 2024 |
|
Jpmorgan Chase & Co | 11k | $16k | 230% | Mar 2024 |
|
Tower Research Capital | 7.9k | $12k | -27% | Mar 2024 |
|
UBS Group | 7.7k | $12k | 100% | Mar 2024 |
|
Bank of America Corporation | 5.6k | $8.6k | 402% | Mar 2024 |
|
Pnc Financial Services | 5.6k | $8.5k | 0% | Mar 2024 |
|
Qube Research & Technologies | 5.4k | $8.3k | 135000% | Mar 2024 |
|
Simplex Trading | 5.3k | $8.0k | -54% | Mar 2024 |
|
Advisor Group Holdings | 1.8k | $2.8k | 80% | Mar 2024 |
|
Atlantic Trust | 1.1k | $1.7k | 100% | Mar 2024 |
|
Rhumbline Advisers | 1.1k | $1.7k | 0% | Mar 2024 |
|
Wells Fargo & Company | 558.00 | $859.320000 | 20% | Mar 2024 |
|
Householder Group Estate & Retirement Specialist | 385.00 | $589.011500 | 0% | Mar 2024 |
|
Creative Financial Designs | 100.00 | $153.000000 | 0% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 2.00 | $3.000000 | 0% | Mar 2024 |
|
Who sold out of Clearside Biomedical?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Water Island Capital | Sep 2023 | 83k | $72k |
Bank of New York Mellon | Dec 2023 | 30k | $35k |
Newman Dignan & Sheerar | Dec 2023 | 28k | $33k |
Wealth Enhancement Advisory Services | Dec 2023 | 20k | $23k |
Acadian Asset Management | Sep 2023 | 18k | $15k |
Virtu Financial | Dec 2023 | 18k | $20k |
Steward Partners Investment Advisory | Dec 2023 | 11k | $13k |
Cutler | Dec 2023 | 2.0k | $2.0k |
Group One Trading | Sep 2023 | 1.6k | $1.4k |
Huntington National Bank | Dec 2023 | 500.00 | $585.000000 |
Scarborough Advisors | Dec 2023 | 277.00 | $324.006900 |
Royal Bank of Canada | Dec 2023 | 225.00 | $0 |